[["index.html", "1 Introductie", " 1 Introductie "],["cv.html", "2 CV 2.1 Education 2.2 Important Courses 2.3 Projects 2.4 Minor Data science for Biology 2.5 Important Skills", " 2 CV Motivated student persuing degree in biomedical sciences, with a big interest in microbiology and data science. Excellent analytical and communication skills. Speaks fluent Dutch and English. Always eager to learn and seeking for new experiences. I am always hard working, organized and capable of working in a team or individual. 2.1 Education Bachelor’s Degree Life Sciences (biomedical sciences), Hogeschool Utrecht (2020-current) • Specializing in microbiology • Minor in Data science for biology part 1 and 2 2.2 Important Courses • Medical Microbiological Diagnosis • Laboratory Tools • Research in Microbiology • Immunology • Experimental Design 2.3 Projects Project Genes &amp; Proteins: Determination of expression of IL-8 with a green fluorescent protein • Researching increased IL-8 protein levels of patients with an RSV infection Project Microbiology: Determination of an infection associated with Neisseria gonorrhoeae of patients • Using PCR and VITEK Project Research Microbiology: Researching the outer membrane vesicles of Porphyromonas gingivalis of patients with parodontitis • Using spectrometry and different isolation methods 2.4 Minor Data science for Biology • Data analysis using R - RNA-sequencing - Metagenomics - Next Generation Sequencing 2.5 Important Skills • MALDI-TOF • VITEK • (Q)PCR • ELISA • Chromotography • Cultering of bacteria "],["maldiquant.html", "3 MALDIquant", " 3 MALDIquant Door mijn intresse in bacteriën en virussen heb ik in mijn derde jaar gekozen voor de specialisatie microbiologie. Hierbij moest ik voor een project werken met de bacterie Porphyromonas gingivalis. De bacterie werd hierbij blootgesteld aan verschillende concentraties magnesium en ijzer. Om het effect hiervan te meten op het aantal uitgescheiden outer membrane vesicles (OMV’s), werd er gebruik gemaakt van een fluorescentie microscoop en MALDI-TOF MS. Voor MALDI-TOF MS data bestaat er een package genaamd MALDIquant, met een complete pipeline voor analyse. Omdat ik de MALDI-TOF MS een interessante techniek vind in de microbiologie, lijkt het me leuk om uit te zoeken hoe deze package werkt. Door op internet informatie te vinden over de package zou ik deze willen toepassen op mijn vorige project om de resultaten die ik toen had en nu heb te vergelijken. Hiermee zou ik in 4 dagen mee kunnen beginnen. De eerste twee dagen zal ik vooral oefenen met het gebruik van de package. Op internet zijn er verschillende manuals te vinden en die zou ik kunnen doorlopen met fake-data. Vervolgens kan ik proberen of ik de package kan laten runnen op mijn eigen data. "],["review.html", "4 Review", " 4 Review An, A.Y. et al. (2023) Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19, bioRxiv. Available at: https://www.biorxiv.org/content/10.1101/2023.11.04.565404v1.full (Accessed: 02 May 2024). Objective To investigate longitudinal changes in gene expression profiles throughout the COVID-19 disease timeline. Methods Three-hundred whole blood samples from 128 adult patients were collected during hospitalization from COVID-19, with up to five samples per patient. Transcriptome sequencing (RNA-Seq), differential gene expression analysis and pathway enrichment was performed. Drug-gene set enrichment analysis was used to identify FDA-approved medications that could inhibit critical genes and proteins at each disease phase. Prognostic gene-expression signatures were generated using machine learning to distinguish 3 disease stages. Results Samples were longitudinally grouped by clinical criteria and gene expression into six disease phases: Mild, Moderate, Severe, Critical, Recovery, and Discharge. Distinct mechanisms with differing trajectories during COVID-19 hospitalization were apparent. Antiviral responses peaked early in COVID-19, while heme metabolism pathways became active much later during disease. Adaptive immune dysfunction, inflammation, and metabolic derangements were most pronounced during phases with higher disease severity, while hemostatic abnormalities were elevated early and persisted throughout the disease course. Drug-gene set enrichment analysis predicted repurposed medications for potential use, including platelet inhibitors in early disease, antidiabetic medications for patients with increased disease severity, and dasatinib throughout the disease course. Disease phases could be categorized using specific gene signatures for prognosis and treatment selection. Disease phases were also highly correlated to previously developed sepsis endotypes, indicating that severity and disease timing were significant contributors to heterogeneity observed in sepsis and COVID-19. Conclusions Higher temporal resolution of longitudinal mechanisms in COVID-19 revealed multiple immune and cellular changes that were activated at different phases of COVID-19. Understanding how a patient’s gene expression profile changes over time can permit more accurate risk stratification of patients and provide time-dependent personalized treatments with repurposed medications. This creates an opportunity for timely intervention before patients transition to a more severe phase, potentially accelerating patients to recovery. "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
